| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 13 May 2025 | 6 May 2025 |
| Advanced Enzyme Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2025 inter alia to consider and approve This is to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday May 13 2025 inter alia to consider the following: 1) To consider & approve annual Financial Statements (Standalone & Consolidated) of the Company for the financial year ended March 31 2025 along with results of the fourth quarter; 2) To consider & recommend Final dividend if any for the financial year ended March 31 2025 and/or to consider & declare Interim Dividend if any for the financial year ended March 31 2026. Please refer to the attached file. (As Per BSE Announcement Dated on:13.05.2025) | ||
| Board Meeting | 8 Feb 2025 | 1 Feb 2025 |
| Advanced Enzyme Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2025 inter alia to consider and approve The Meeting of Board of Directors of the Company is scheduled to be held on Saturday February 08 2025 inter alia to consider and approve the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31 2024. With reference to the notice of Board Meeting dated February 01, 2025, we hereby inform that the Board of Directors at its Meeting held on February 08, 2025 has inter-alia approved the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended December 31, 2024 Advanced Enzyme Technologies Limited has informed the Exchange about the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quater and nine months ended December 31, 2024 The aforesaid financial results are also being uploaded on the website of the Company i.e. www.advancedenzymes.com (As Per BSE Announcement Dated on 08/02/2025) | ||
| Board Meeting | 9 Nov 2024 | 30 Oct 2024 |
| Quarterly Results Advanced Enzyme Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2024 ,inter alia, to consider and approve Meeting of Board of Directors of the Company is scheduled to be held on Saturday, November 09, 2024, inter alia, to consider and approve the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2024. (As Per BSE Announcement dated on 30.10.2024) With reference to the notice of Board Meeting dated November 09, 2024, we hereby inform that the Board of Directors at its Meeting held on November 09, 2024 has inter-alia approved the Unaudited Financial Results (Standalone & Consolidated ) of the Company for the quarter and half year ended September 30, 2024 (As Per BSE Announcement Dated on 09.11.2024) | ||
| Board Meeting | 10 Aug 2024 | 2 Aug 2024 |
| Advanced Enzyme Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2024 inter alia to consider and approve This is to inform that the Meeting of Board of Directors of Company is scheduled to be held on Saturday August 10 2024 inter alia to consider and approve Un-audited Financial Results(Standalone and Consolidated) of the Company for the quarter ended June 30 2024. Further to our letter dated June 28 2024 intimating closure of Trading Window we wish to inform you that the Trading Window for dealing in the Securities of the Company will continue to remain closed up to August 12 2024 Copy of this intimation / notice is also being uploaded on the website of the Company at www.advancedenzymes.com and can be accessed on the website of the Stock Exchanges i.e. www.bseindia.com and www.nseindia.com. This is to inform you that the Board of Directors at its Meeting held on August 10, 2024 has inter alia, approved the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2024. Read less.. (As Per BSE Announcement Dated on 10.08.2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
